Attachment Inhibitor Comparison in Heavily Treatment Experienced Patients
What is the purpose of this trial?
The purpose of this study is to determine whether the BMS Attachment Inhibitor (BMS-663068) is effective in the treatment of heavily treatment experienced HIV-1 patients with multi-drug resistance.
- Ages18 years and older
- Trial withViiV Healthcare Company
- Start Date02/27/2018
- End Date08/17/2016
- Last Updated10/15/2019
- Study HIC#2000023674